Ivan Lazarte net worth
Quick answer
Ivan Lazarte's estimated net worth is $6.67M (range $4.67M – $10.0M) as of 2026. Ivan Lazarte is Founder at Exin Therapeutics. Exin Therapeutics valuation.
Ivan Lazarte is Founder at Exin Therapeutics (YC W25). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Active
- Region: United States of America
- Industries: Healthcare, Therapeutics
- Team size: 9
- Website: https://www.exintherapeutics.com/
Who is Ivan Lazarte?
Ivan Lazarte is a founder of Exin Therapeutics, a company that participated in Y Combinator's W25 batch.
Highlights:
- Y Combinator W25
- Exin Therapeutics
About Exin Therapeutics
We use AI and high-throughput mouse studies to discover therapeutics that modify neural activity in the brain. The initial focus is on epilepsies associated with autism and Parkinson’s disease with the potential to expand to any neurological disorder underlined by a dysfunction in neural activity. Our R&D is guided by AI models trained on high-density multimodal mouse data generated in-house.
We are 3...
FAQ: Ivan Lazarte net worth and Exin Therapeutics valuation
What is Ivan Lazarte's net worth?
Ivan Lazarte's estimated net worth is $6.67M (range $4.67M – $10.0M) as of 2026. Ivan Lazarte is Founder at Exin Therapeutics. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.
What is Exin Therapeutics valuation?
Exin Therapeutics's estimated valuation on Entrepreneurial Check is $20.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.
What is Ivan Lazarte's role?
Ivan Lazarte is Founder at Exin Therapeutics, a Y Combinator-backed startup (batch W25).